Label-free luminescent mesoporous silica nanoparti-cles for imaging and drug delivery

Theranostics

Volumn 3, Issue 9, 2013, Pages 650-657

  Chen, Hongmin ^a   Zhen, Zipeng ^a   Tang, Wei ^a   Todd, Trever ^a   Chuang, Yen Jun ^b   Wang, Lianchun ^a   Pan, Zhengwei ^b   Xie, Jin ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b University of Georgia   (United States)

Author keywords

Bioimaging; Doxorubicin; Drug delivery; Integrin avp3; Silica nanoparticles

Indexed keywords

DOXORUBICIN; NANOPARTICLE; SILICA NANOPARTICLE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL; CYTOTOXICITY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; GLIOBLASTOMA; HISTOLOGY; IMMUNOFLUORESCENCE; LUMINESCENCE; MATERIAL COATING; PARTICLE SIZE; PH; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; ULTRAVIOLET IRRADIATION;

BIOIMAGING; DOXORUBICIN.; DRUG DELIVERY; INTEGRIN ΑVΒ3; SILICA NANOPARTICLES;

ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; HUMANS; NANOPARTICLES; NEOPLASMS; OLIGOPEPTIDES; OPTICAL IMAGING; SILICON DIOXIDE;

EID: 84883178355     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.6668     Document Type: Article

References (58)

1. Xie J, Liu G, Eden HS, Ai H, Chen X. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res. 2011; 44: 883-92.
2. Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev. 2010; 62: 1064-79.
3. Lin X, Xie J, Niu G, Zhang F, Gao H, Yang M, et al. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett. 2011; 11: (814)-(9) .
4. Muhammad F, Guo M, Qi W, Sun F, Wang A, Guo Y, et al. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. J Am Chem Soc. 2011; 133: 8778-81.
5. Liu H, Chen D, Li L, Liu T, Tan L, Wu X, et al. Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew Chem Int Ed Engl. 2011; 50: 891-5.
6. Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, Brown PA, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater. 2011; 10: 389-97.
7. Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small. 2007; 3: 1341-6.
8. Erathodiyil N, Ying JY. Functionalization of inorganic nanoparticles for bioimaging applications. Acc Chem Res. 2011; 44: 925-35.
9. Guerrero-Martinez A, Perez-Juste J, Liz-Marzan LM. Recent progress on silica coating of nanoparticles and related nanomaterials. Adv Mater. 2010; 22: 1182-95.
10. Xie J, Zhang F, Aronova M, Zhu L, Lin X, Quan Q, et al. Manipulating the power of an additional phase: a flower-like Au-Fe3O4 optical nanosensor for imaging protease expressions in vivo. ACS Nano. 2011; 5: 3043-51.
11. Mikhaylov G, Mikac U, Magaeva AA, Itin VI, Naiden EP, Psakhye I, et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat Nanotech. 2011; 6: 594-602.
12. Fan K, Cao C, Pan Y, Lu D, Yang D, Feng J, et al. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nat Nanotech. 2012; 7: 833.
13. Lin X, Xie J, Zhu L, Lee S, Niu G, Ma Y, et al. Hybrid Ferritin Nanoparticles as Activatable Probes for Tumor Imaging. Angew Chem Int Ed Engl. 2011; 50: 1569-72.
14. Valero E, Tambalo S, Marzola P, Ortega-Munoz M, Lopez-Jaramillo FJ, Santoyo-Gonzalez F, et al. Magnetic nanoparticles--templated assembly of protein subunits: a new platform for carbohydrate-based MRI nanoprobes. J Am Chem Soc. 2011; 133: 4889-95.
15. Zrazhevskiy P, Sena M, Gao X. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem Soc Rev. 2010; 39: 4326-54.
16. Bagalkot V, Gao X. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing. ACS Nano. 2011; 5: 8131-9.
17. Park JH, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater. 2009; 8: 331-6.
18. Ang LY, Lim ME, Ong LC, Zhang Y. Applications of upconversion nanoparticles in imaging, detection and therapy. Nanomedicine (Lond). 2011; 6: 1273-88.
19. Yavuz MS, Cheng Y, Chen J, Cobley CM, Zhang Q, Rycenga M, et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater. 2009; 8: 935-9.
20. Benachour H, Seve A, Bastogne T, Frochot C, Vanderesse R, Jasniewski J, et al. Multifunctional Peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI. Theranostics. 2012; 2: 889-904.
21. Hu X, Gao X. Silica-polymer dual layer-encapsulated quantum dots with remarkable stability. ACS Nano. 2010; 4: 6080-6.
22. Idris NM, Gnanasammandhan MK, Zhang J, Ho PC, Mahendran R, Zhang Y. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med. 2012; 18: 1580-U190.
23. Qian HS, Guo HC, Ho PCL, Mahendran R, Zhang Y. Mesoporous-Silica-Coated Up-Conversion Fluorescent Nanoparticles for Photodynamic Therapy. Small. 2009; 5: 2285-90.
24. Auger A, Samuel J, Poncelet O, Raccurt O. A comparative study of non-covalent encapsulation methods for organic dyes into silica nanoparticles. Nanoscale Res Lett. 2011;6(1):328.
25. Wang L, Wang KM, Santra S, Zhao XJ, Hilliard LR, Smith JE, et al. Watching silica nanoparticles glow in the biological world. Anal Chem. 2006; 78: 646-54.
26. Kim J, Kim HS, Lee N, Kim T, Kim H, Yu T, et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed Engl. 2008; 47: 8438-41.
27. Chen H, He J. Fine control over the morphology and structure of mesoporous silica nanomaterials by a dual-templating approach. Chem Commun. 2008;: 4422-4.
28. Gu J, Fan W, Shimojima A, Okubo T. Organic-inorganic mesoporous nanocarriers integrated with biogenic ligands. Small. 2007; 3: 1740-4.
29. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol. 2005; 16: 63-72.
30. Gao Y, Chen Y, Ji X, He X, Yin Q, Zhang Z, et al. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS Nano. 2011; 5: 9788-98.
31. Troy T, Jekic-McMullen D, Sambucetti L, Rice B. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging. 2004; 3: 9-23.
32. Li L, Tang F, Liu H, Liu T, Hao N, Chen D, et al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano. 2010; 4: 6874-82.
33. Gao F, Li L, Liu T, Hao N, Liu H, Tan L, et al. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects. Nanoscale. 2012; 4: 3365-72.
34. Ye Y, Chen X. Integrin targeting for tumor optical imaging. Theranostics. 2011; 1: 102-26.
35. Chen K, Chen X. Integrin targeted delivery of chemotherapeutics. Theranostics. 2011; 1: 189-200.
36. Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano lett. 2006; 6: 669-76.
37. Li Y, Li Z, Wang X, Liu F, Cheng Y, Zhang B, et al. In vivo cancer targeting and imaging-guided surgery with near infrared-emitting quantum dot bioconjugates. Theranostics. 2012; 2: 769-76.
38. Guo W, Chen N, Tu Y, Dong C, Zhang B, Hu C, et al. Synthesis of Zn-Cu-In-S/ZnS core/shell quantum dots with inhibited blue-shift photoluminescence and applications for tumor targeted bioimaging. Theranostics. 2013; 3: 99-108.
39. Lunov O, Syrovets T, Loos C, Beil J, Delacher M, Tron K, et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano. 2011; 5: 1657-69.
40. Choi CH, Zuckerman JE, Webster P, Davis ME. Targeting kidney mesangium by nanoparticles of defined size. Proc Natl Acad Sci U S A. 2011; 108: 6656-61.
41. Inoue Y, Izawa K, Kiryu S, Tojo A, Ohtomo K. Diet and abdominal autofluorescence detected by in vivo fluorescence imaging of living mice. Mol Imaging. 2008; 7: 21-7.
42. Bhaumik S, DePuy J, Klimash J. Strategies to minimize background autofluorescence in live mice during noninvasive fluorescence optical imaging. Lab Anim (NY). 2007; 36: 40-3.
43. Chen X. Integrin Targeted Imaging and Therapy. Theranostics. 2011; 2011: 28-9.
44. Lim EH, Danthi N, Bednarski M, Li KC. A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis. Nanomedicine (Lond). 2005; 1: 110-4.
45. Wang L, Estevez MC, O'Donoghue M, Tan W. Fluorophore-free luminescent organosilica nanoparticles. Langmuir. 2008; 24: 1635-9.
46. Jakob AM, Schmedake TA. A novel approach to monodisperse, luminescent silica spheres. Chem Mater. 2006; 18: 3173-5.
47. Green WH, Le KP, Grey J, Au TT, Sailor MJ. White phosphors from a silicate-carboxylate sol-gel precursor that lack metal activator ions. Science. 1997; 276: 1826-8.
48. Anilkumar P, Cao L, Yu JJ, Tackett KN, 2nd, Wang P, Meziani MJ, et al. Crosslinked carbon dots as ultra-bright fluorescence probes. Small. 2013; 9: 545-51.
49. Bourlinos AB, Stassinopoulos A, Anglos D, Zboril R, Karakassides M, Giannelis EP. Surface functionalized carbogenic quantum dots. Small. 2008; 4: 455-8.
50. Tao H, Yang K, Ma Z, Wan J, Zhang Y, Kang Z, et al. In Vivo NIR Fluorescence Imaging, Biodistribution, and Toxicology of Photoluminescent Carbon Dots Produced from Carbon Nanotubes and Graphite. Small. 2011.
51. Wang X, Cao L, Yang ST, Lu F, Meziani MJ, Tian L, et al. Bandgap-like strong fluorescence in functionalized carbon nanoparticles. Angew Chem Int Ed Engl. 2010; 49: 5310-4.
52. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A. 2006; 103: 6315-20.
53. Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol. 2007; 2: 47-52.
54. Li LY, Wartchow CA, Danthi SN, Shen ZM, Dechene N, Pease J, et al. A novel antiangiogenesis therapy using an integrin antagonist or anti-FLK-1 antibody coated Y-90-labeled nanoparticles. Int J Radiat Oncol. 2004; 58: 1215-27.
55. Liu J, Pang Y, Huang W, Huang X, Meng L, Zhu X, et al. Bioreducible micelles self-assembled from amphiphilic hyperbranched multiarm copolymer for glutathione-mediated intracellular drug delivery. Biomacromolecules. 2011; 12: 1567-77.
56. Russo A, DeGraff W, Friedman N, Mitchell JB. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res. 1986; 46: 2845-8.
57. Sorkin A, Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Biol. 2002; 3: 600-14.
58. Huotari J, Helenius A. Endosome maturation. EMBO J. 2011; 30: 3481-500